BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29459674)

  • 1. Identification of novel prognosis-related genes associated with cancer using integrative network analysis.
    Wee Y; Liu Y; Lu J; Li X; Zhao M
    Sci Rep; 2018 Feb; 8(1):3233. PubMed ID: 29459674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pan-cancer study of copy number gain and up-regulation in human oncogenes.
    Wee Y; Wang T; Liu Y; Li X; Zhao M
    Life Sci; 2018 Oct; 211():206-214. PubMed ID: 30243646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of epithelial-mesenchymal transition-related genes increases with copy number in multiple cancer types.
    Zhao M; Liu Y; Qu H
    Oncotarget; 2016 Apr; 7(17):24688-99. PubMed ID: 27029057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma.
    Kumar R; Patiyal S; Kumar V; Nagpal G; Raghava GPS
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance between somatic copy number loss and down-regulated expression: A pan-cancer study of cancer predisposition genes.
    Wei R; Zhao M; Zheng CH; Zhao M; Xia J
    Sci Rep; 2016 Dec; 6():37358. PubMed ID: 27929028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
    Zhao M; Zhao Z
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
    Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying prognostic signature in ovarian cancer using DirGenerank.
    Wang JY; Chen LL; Zhou XH
    Oncotarget; 2017 Jul; 8(28):46398-46413. PubMed ID: 28615526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a prognostic signature based on copy number variations (CNVs) and CNV-modulated gene expression in acute myeloid leukemia.
    Niu C; Wu D; Li AJ; Qin KH; Hu DA; Wang EJ; Tucker AB; He F; Huang L; Wang H; Liu Q; Ni N; Shi D; Zhao X; Wan Y; Li T; He T; Liao P
    Am J Transl Res; 2021; 13(12):13683-13696. PubMed ID: 35035707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer.
    Song BN; Kim SK; Chu IS
    Exp Mol Med; 2017 Jan; 49(1):e282. PubMed ID: 28082741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer.
    Yu C; Hong H; Lu J; Zhao X; Hu W; Zhang S; Zong Y; Mao Z; Li J; Wang M; Feng B; Sun J; Zheng M
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806905. PubMed ID: 30336768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
    Li H; Liu JW; Liu S; Yuan Y; Sun LP
    Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
    Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
    Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
    Li X; Tian R; Gao H; Yang Y; Williams BRG; Gantier MP; McMillan NAJ; Xu D; Hu Y; Gao Y
    Sci Rep; 2017 Nov; 7(1):16495. PubMed ID: 29184082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. System-scale network modeling of cancer using EPoC.
    Abenius T; Jörnsten R; Kling T; Schmidt L; Sánchez J; Nelander S
    Adv Exp Med Biol; 2012; 736():617-43. PubMed ID: 22161356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Data mining of esophageal squamous cell carcinoma from The Cancer Genome Atlas database].
    He SY; Wang XB; Jiao YC
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):517-522. PubMed ID: 30060360
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.
    Guo S; Yang J; Wu M; Xiao G
    Pathol Res Pract; 2019 May; 215(5):1003-1011. PubMed ID: 30910254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.
    Wang X; Wang SS; Zhou L; Yu L; Zhang LM
    J Ovarian Res; 2016 Nov; 9(1):73. PubMed ID: 27806724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.